Abstract
36P Comparison of pelitinib, tepotinib or docetaxel efficacy according to the copy number or gene alteration status of EGFR, MET, HRAS, KRAS and NRAS genes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have